![](img/space.gif) |
Regulatory role of miRNA network in acute renal failure
|
Help
Print
|
Here you can view and search the projects funded by NKFI since 2004
Back »![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
|
![](img/print_ver.gif) |
List of publications |
|
|
Kaucsar T, Revesz C, Godo M, Krenacs T, Albert M, Szalay C, Rosivall L, Benyo Z, Batkai S, Thum T, Szénási G, Hamar P: Activation of the miR-17 Family and miR-21 During Murine Kidney Ischemia-Reperfusion Injury., NUCLEIC ACID THERAPEUTICS 23:(5) pp. 344-354. (2013), 2013 | Kaucsár T, Bodor C, Godó M, Szalay C, Révész C, Németh Z, Mózes M, Szénási G, Rosivall L, Sőti C, Hamar P.: LPS-induced delayed preconditioning is mediated by Hsp90 and involves the heat shock response in mouse kidney., PLoS One., 2014 | Racz Z, Godo M, Revesz C, Hamar P: Immune activation and target organ damage are consequences of hydrodynamic treatment but not delivery of naked siRNAs in mice., NUCL ACID THERAP 21: (3) 215-224, 2011 | Kaucsar T, Racz Z, Hamar P: Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease, ADV DRUG DELIVER REV 62: (14) 1390-1401, 2010 | Lorenzen JM, Kaucsar T, Schauerte C, Schmitt R, Rong S, Hübner A, Scherf K, Fiedler J, Martino F, Kumarswamy R, Kölling M, Sörensen I, Hinz H, Heineke J, van Rooij E, Haller H, Thum T.: MicroRNA-24 Antagonism Prevents Renal Ischemia Reperfusion Injury., J Am Soc Nephrol, 2014 | Révész Cs, Kaucsár T, Rácz Zs, Godó M, Hamar P: Silencing oxidases with RNAi does not prevent renal ischemia/reperfusion injury in mice, RNAi & miRNA Europe, 2011 | Hamar P: Role of Regulatory Micro RNAs in Type 2 Diabetes Mellitus-Related Inflammation, NUCL ACID THERAP 22: (5) 289-294, 2012 | Kaucsár T, Révész Cs, Godó M, Tarszabó R, Rácz Zs, Hamar P: MicroRNA expression pattern in renal ischemia-reperfusion injury, RNAi & miRNA Europe 2011, 2011 | Revesz Cs, Hamar P: Delivery Methods to Target RNAs in the Kidney., Gene Therapy Applications, InTech, pp. 263-278., 2011 | Stokman G, Qin Y, Racz Z, Hamar P, Price LS: Application of siRNA in targeting protein expression in kidney disease, ADV DRUG DELIVER REV 62: (14) 1378-1389, 2010 | Hamar P: Role of Regulatory Micro RNAs in Type 2 Diabetes Mellitus-Related Inflammation., Nucleic Acid Ther, 2012 | Masszi G, Buday A, Novak A, Horvath EM, Tarszabo R, Sara L, Revesz Cs, Benko R, Nadasy GyL, Benyo Z, Hamar P, Varbiro Sz: Altered insulin-induced relaxation of aortic rings in a dihydrotestosterone-induced rodent model of polycystic ovary syndrome, Fertility and sterility, 2012 | Fintha A, Gasparics A, Fang L, Erdei Zs, Hamar P, Mózes M, Kökény G, Rosivall L, Sebe A: Characterization and role of SCAI during renal fibrosis and epithelial-mesenchymal transition, Am J Pathol, 2013 | Masszi G, Novak A, Tarszabo R, Horvath EM, Buday A, Ruisanchez E, Tokes AM, Sara L, Benko R, Nadasy GL, Revesz Cs, Hamar P, Benyó Z, Várbíró Sz: Effects of vitamin D3 derivate calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model, Pharmacol Rep, 2013 | Máthé Cs, Szénási G, Sebestény A, Blázovics A, Szentmihályi K, Hamar P, Albert M: Protective effect of CV247 against cisplatin nephrotoxicity in rats, Hum Exp Toxicol, 2013 | Fintha A, Gasparics A, Fang L, Erdei Zs, Hamar P, Mózes M, Kökény G, Rosivall L, Sebe A: Characterization and role of SCAI during renal fibrosis and epithelial-mesenchymal transition, Am J Pathol, 2013 | Wasik AA, Koskelainen S, Hyvönen ME, Musante L, Lehtonen E, Koskenniemi K, Tienari J, Vaheri A, Kerjaschki D, Szalay C, Révész C, Varmanen P, Nyman TA, Hamar P, Holthöfer H, Lehtonen S.: Ezrin is down-regulated in diabetic kidney glomeruli and regulates actin reorganization and glucose uptake via GLUT1 in cultured podocytes., Am J Pathol., 2014 | Hamar P, Wang M, Godó M, Kökény G, Ouyang N, Heemann U: Lupus nephritis reocurrs following transplantation in the lupus prone mouse., Lupus, 19:175-81, 2010 | Kökény G, Németh Z, Godó M, Hamar P: The Rowett rat strain is resistant to renal fibrosis, Nephrol Dial Transpl, 25:1458-62, 2010 | Rácz Zs, Nagy E, Rosivall L, Szebeni J, Hamar P: Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus., Lupus, 2010 | Buday A, Őrsy P, Godó M, Mózes M, Kökény G, Lacza Zs, Koller A, Ungvári Z, Gross ML, Benyó Z, Hamar P: Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase driven superoxide production and leads to hypertension, myocardial remode, Am J Physiol Heart Circ Physiol, 299: H386-95., 2010 | Kaucsár T, Rácz Zs, Hamar P: Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease, Adv Drug Delivery Rev, 30: 1390-401., 2010 | Stokman G, Qin Y, Rácz Zs, Hamar P, Price LS: Application of siRNA in targeting protein expression in kidney disease, Adv Drug Delivery Rev, 30: 1378-89., 2010 | Baintner K, Kocsis B, Kovács K, Péterfi Z, Kökény G, Hamar P: Interaction of concanavalin A with bacterial lipopolysaccharides in agarose gel., ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 58: pp. 201-209., 2011 | Fugmann T, Borgia B, Révész C, Godó M, Forsblom C, Hamar P, Holthöfer H, Neri D, Roesli C: Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy., KIDNEY INTERNATIONAL 80:(3) pp. 272-281. p. 9, 2011 | Racz Z, Godo M, Hamar P: Immune activation and target organ damage are consequences of hydrodynamic treatment but not delivery of naked siRNAs in mice., NUCLEIC ACID THERAPEUTICS 21:(3) pp. 215-224., 2011 | Rácz Zs, Kaucsár T, Hamar P: The huge world of small RNAs: regulating networks of microRNAs., ACTA PHYSIOLOGICA HUNGARICA 98:(3) 243 p. Paper 251. p. 9, 2011 | Revesz C, Hamar P: Delivery Methods to Target RNAs in the Kidney., Gene Therapy Applications, InTech, pp. 263-278., 2011 | Tamás Kaucsár, Csaba Révész, Mária Godó, Tarszabó Róber, Zsuzsanna Rácz, Péter Hamar: MicroRNA expression pattern in renal ischemia-reperfusion injury, RNAi & miRNA Europe 2011, 2011 | Kaucsár T, Révész Cs, Godó M, Rácz Zs, Tarszabó R Hamar P: A microRNS-ek szerepe vese ischaemia-reperfúziós károsodásban, Hyperton és Neph 2011;15(suppl 3): s36, 2011 | Sara L, Antal P, Masszi G, Buday A, Horvath EM, Hamar P, Monos E, Nadasy GL, Varbiro S: Arteriolar insulin resistance in a rat model of polycystic ovary syndrome., FERTILITY AND STERILITY 97:(2) pp. 462-468., 2012 | Csaba Révész, Tamás Kaucsár, Zsuzsanna Rácz, Mária Godó, Péter Hamar: Silencing oxidases with RNAi does not prevent renal ischemia/reperfusion injury in mice, RNAi & miRNA Europe, 2011 | Fugmann T, Borgia B, Révész C, Godó M, Forsblom C, Hamar P, Holthöfer H, Neri D, Roesli C: Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy., KIDNEY INT 80: (3) 272-281, 2011 | Máthé Cs, Szénási G, Sebestény A, Blázovics A, Szentmihályi K, Hamar P, Albert M: Protective effect of CV247 against cisplatin nephrotoxicity in rats, Hum Exp Toxicol, 2013 | Masszi G, Horvath EM, Tarszabo R, Benko R, Novak A, Buday A, Tokes AM, Nadasy GL, Hamar P, Benyó Z, Varbiro S.: Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS)., PLoS One, 2013 | Masszi G, Buday A, Novak A, Horvath EM, Tarszabo R, Sara L, Revesz C, Benko R, Nadasy GL, Benyó Z, Hamar P, Varbiro S.: Altered insulin-induced relaxation of aortic rings in a dihydrotestosterone-induced rodent model of polycystic ovary syndrome., Fertil Steril, 2013 | Masszi G, Benko R, Csibi N, Horvath EM, Tokes AM, Beres NJ, Tarszabo R, Buday A, Repas Cs, Bekesi G, Patocs A, Nadasy GyL, Hamar P, Benyo Z, Varbiro Sz: Endothelial relaxation mechanisms and nitrative stress is partly restored by Vitamin D3 therapy in a rat model of polycystic ovary syndrome, LIFE SCIENCES, 2013 | Saleh HM, Koeleman B, Szénási G, Rosivall L, Hamar P: Association of CTLA-4 Polymorphisms with Type 1 Diabetes in the Egyptian Population, J Diabetes Metab, 2013 | Tóth A, Kocsis B, Damjanova I, Kristóf K, Jánvári L, Pászti J, Csercsik R, Topf J, Szabó D, Hamar P, Nagy K, Füzi M.: Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase., Eur J Clin Microbiol Infect Dis., 2014 |
![](img/space.gif)
|
|
|
![](img/shadow_right_up.gif)
|
![](img/shadow_left_bottom.gif)
|
![](img/shadow_right_bottom.gif)
|
![](img/space.gif) Back »
|
![](img/space.gif) |
|